English
Deutsch
Français
Nederlands
Español
Reset. Heal. Grow.
Psychedelics and Parenting: How Plant Medicine Helps Break Generational Trauma
There's a question that quietly sits underneath a lot of the conversations I have with parents considering plant medicine. They don't usually lead with it. It comes out later, around hour two of an interview, after the small talk and the careful framing. I don't want to do to my kid what was done to me. That sentence — in some shape or other — is showing up everywhere right now. In retreat intake forms. In therapist offices. At small psychedelic society gatherings in Brooklyn lofts where parents drink kombucha and ask whether psilocybin can help them stop yelling at their five-year-old over spilled juice. The intersection of psychedelics, addiction recovery, and parenting has become one of the most interesting — and least talked about — corners of the plant medicine world. So let's actually talk about it. What's the evidence? What are people experiencing? And if you're a parent quietly googling this at 1am, what should you actually know before going further? The pattern I keep hearing goes like this. A parent — usually somewhere between their late twenties and mid-forties — has a kid. Things they thought they'd processed start surfacing. The childhood they swore they'd never repeat starts leaking out in small, embarrassing ways. They snap. They withdraw. They overcompensate. They lie awake wondering whether the irritability they feel toward their toddler is normal exhaustion or something older, deeper, and more inherited. Conventional talk therapy helps some people with this. It plateaus for others. And that plateau is often where psychedelics enter the conversation — not as a party drug, not as a spiritual badge, but as a tool people are using to dig into stuck places they can't seem to reach any other way. One mother I spoke with described it bluntly: she realized she was reliving her own childhood every time she held her daughter. The dark memories weren't past tense. They were running on a loop, and they were shaping the way she mothered. Microdosing LSD, paired with therapy, was what finally interrupted the loop. Her words, not mine: she wanted the cycle to end with her. Here's where I want to be careful, because there's a lot of breathless reporting in this space and it does nobody any favors. The honest version: The mechanism researchers keep pointing to involves something called the default mode network. Think of it as the brain's autopilot — the part that hums in the background, running your habits of thought, your sense of self, your endlessly looping internal monologue. In people with depression, trauma, and addiction, that network tends to get rigid. Stuck. Rutted in. Psychedelics appear to temporarily quiet that network. The ego loosens its grip. The repetitive thought patterns lose some of their grooves. And in that opening, people often report being able to see their own lives — including their parenting — with a clarity they didn't have before. Whether that opening turns into lasting change depends almost entirely on what happens after the experience ends. More on that in a minute. In the Amazonian traditions ayahuasca comes from, plants like the vine, chacruna, tobacco, and others are called master plants — teachers, essentially. The framing is different from how Western medicine thinks about a drug. You're not taking a substance to fix a symptom. You're entering into a relationship with a plant that, in the tradition's view, has something to show you. I bring this up because the parents I've met who get the most out of plant medicine tend to approach it more like the second framing than the first. They're not chasing a fix. They're going in with a question — often a question about their own childhood, their own parents, the lineage they're now extending into another generation. And they're prepared for the plant to answer in ways they didn't expect. This is also why retreat context matters so much. A weekend in a maloca in the Sacred Valley with experienced facilitators is a fundamentally different experience from drinking brew in a friend's apartment. Same molecule. Wildly different container. I'm going to put on my journalist hat for this section because the cheerleading in plant medicine media is genuinely irresponsible sometimes. Psychedelics are physiologically safe for most healthy people. They're not addictive in the conventional sense. Overdose is essentially impossible with classical psychedelics like psilocybin and LSD. Those things are true and worth saying. And — here come the caveats: One of the most common reasons parents I interview are looking at this path is addiction. Alcohol, often. Pills sometimes. Stimulants occasionally. The pattern of using a substance to manage feelings they don't have language for — and watching themselves do it in front of their kids. Ibogaine has the most dramatic clinical track record for interrupting opioid dependence, though it carries cardiac risks that require medical supervision and proper screening. Ayahuasca has been studied in addiction contexts in Brazil and Canada with promising results. Psilocybin trials at Johns Hopkins have shown meaningful effects on smoking cessation and alcohol use disorder. The thing these substances seem to share is the capacity to give people a clear, embodied glimpse of why they've been using — what wound the substance was covering, what feeling it was numbing. That glimpse, on its own, doesn't fix anything. But for some people it provides enough leverage to start doing the work that does. If you've read this far, you're probably weighing whether to actually do this. Here's the practical guidance I'd give a friend in your position. First, get your house in order before you book anything. That means childcare for the duration of the retreat plus at least a week after — integration is not optional, and it takes time. It means telling your partner what you're doing and why. It means lining up a therapist for the weeks after, ideally one with experience supporting psychedelic integration. Second, vet the retreat hard. Ask about facilitator training and lineage. Ask about medical screening. Ask what happens if something goes sideways at 3am. Ask about the ratio of facilitators to participants. Ask how they handle medication interactions. A serious operation will answer all of this clearly. A sketchy one will deflect. Third, get specific about your intention. "I want to heal" is too vague to be useful. "I want to understand why I shut down when my daughter cries" is the kind of intention that actually gives the experience something to work on. Fourth — and this is the part most retreats undersell — plan your integration. The ceremony is maybe 15% of the work. The other 85% is what you do in the months that follow, when the insights have to translate into how you actually behave at the dinner table. For readers who want to explore this further, a range of carefully selected ayahuasca and plant medicine retreats can be browsed on our marketplace here. The parents I've met who've benefited most from this work didn't come back transformed in a flash. They came back with a thread to pull on. They pulled on it, in therapy, in relationships, in the quiet daily decisions of how to be present with a child. That's where the cycle actually breaks. Not in the ceremony. In the Tuesday morning after, and the one after that, and the one after that.
Is Cannabis a Psychedelic? What Psychiatrists Are Quietly Rethinking
Cannabis doesn’t usually get invited to the psychedelic dinner party. Mushrooms show up. Ayahuasca shows up. LSD wanders in late, talking about set and setting. Weed gets left on the porch with a bag of chips. But a small, persistent group of psychiatrists keep arguing it deserves a seat at the table — and the reasoning is more interesting than the stoner-meets-shaman cliché suggests. The premise is simple. Real psychedelics shift how you perceive the familiar. They strip the varnish off habit. Some researchers think cannabis — at certain doses, in certain people, in certain contexts — does a softer version of the same trick. Not the fireworks of a high-dose mushroom journey. More like a side door into the same room. This matters because the conversation around plant medicine, addiction, and master plants is widening fast. If cannabis genuinely belongs in that conversation, it changes how clinicians, retreat-goers, and policymakers think about an enormous, already-legal substance. If it doesn’t, the framing risks muddying the waters of real psychedelic-assisted therapy. Worth taking seriously either way. The case usually hinges on a clinical concept called dehabituation — the moment your brain stops auto-completing reality and actually looks at it again. You’ve felt this without any drug at all. The first morning of a vacation, when the light in a strange room hits you differently. The week after a breakup, when your own apartment looks like someone else’s. That fresh-eyes effect is what some psychiatrists believe cannabis can produce on demand, in lower-stakes form. Julie Holland, a New York psychiatrist who’s written extensively about psychoactive substances, has argued exactly this at psychedelic science conferences. Her phrasing — that cannabis can make everything old feel new again — is a tidy way of describing what therapists already chase in the consulting room. A lot of talk therapy is, at root, a perspective problem. You’re stuck in a loop. Something jolts the loop. The loop loosens. Insight follows. That’s also why psychiatry and psychedelics share a Latin root — psyche, the mind. Both act on it. They just work at different intensities, with different risks, and on different timelines. Calling cannabis psychedelic isn’t saying it’s the same as ayahuasca. It’s saying the mechanism — interruption of automatic perception — sits on a shared spectrum. The reason any of this is being discussed seriously now is the larger resurgence in psychedelic research. After decades of regulatory deep-freeze, psilocybin, MDMA, LSD, ayahuasca, and ibogaine are all back in clinical trials for depression, end-of-life anxiety, treatment-resistant PTSD, and addiction. Some of the results have been striking — striking enough that the FDA designated psilocybin a breakthrough therapy and MDMA-assisted therapy has moved through late-stage trials. Inside that wave, cannabis is the weird cousin. It’s been studied for chronic pain, nausea, sleep, and PTSD symptom management — Holland herself has worked as a medical monitor on a MAPS-led study examining marijuana for PTSD in veterans. But it sits in a category of its own at the DEA, which has historically made serious research painfully slow. So we’re left with a lot of anecdote, a growing pile of preliminary data, and very few clean answers. For anyone weighing a plant-medicine retreat, this matters in a specific way. Cannabis is sometimes folded into ceremonial work — in some traditions it’s used as a master plant in its own right, with dieta-like preparation, intention setting, and integration. In other traditions it’s seen as a distraction from deeper work. Both views have weight. Knowing which framing your facilitators hold is part of doing your due diligence. Here’s what the more measured proponents actually claim: None of that is the same as saying weed cures depression or replaces ayahuasca. It’s saying the plant has psychoactive properties that, used carefully, might be useful in a clinical or contemplative context. That’s a smaller, more defensible claim — and it’s the one worth taking forward. Cannabis also has a complicated relationship with mental health, and pretending otherwise serves nobody. The most comprehensive review of marijuana research to date — a sprawling National Academies report — found that heavier, more frequent use is associated with elevated risk of psychosis, social anxiety, and to a lesser degree, depression. The report couldn’t cleanly say whether cannabis causes those outcomes or whether people predisposed to them simply self-medicate more often. Probably some of both. The question is far from settled. What this means practically: cannabis is not a neutral tool. For some people it’s a quiet ally. For others, especially those with a family history of psychosis, heavy use can be genuinely destabilizing. The difference between the two camps isn’t always obvious until something cracks. And unlike a ceremonial psychedelic, cannabis is easy to use every day — which is where the dehabituation effect tends to invert. The thing that once made everything feel new becomes the thing you reach for to feel normal. That’s not insight. That’s dependence with extra steps. This is also the part of the conversation that gets skipped at parties. People love to hear that their daily habit might be secretly therapeutic. Fewer people love hearing that daily use probably blunts the very effect that made it interesting in the first place. If you’re researching ayahuasca, psilocybin, ibogaine, or another plant-medicine retreat, cannabis-as-psychedelic is mostly a tangent — but a useful one to think through before you go. Three practical points: The deeper point is that addiction and habituation exist on a continuum, and so do the tools we use to address them. Master plants like ayahuasca, iboga, and huachuma sit at the heavier end of that toolkit. Cannabis, used intentionally, may sit somewhere closer to the middle. Daily habit-use sits at the other end entirely — closer to the problem than to the solution. The honest answer is: slowly. Cannabis remains federally restricted in ways that make rigorous psychiatric study harder than it should be, even as more than half of U.S. states have legalized some form of access. The mismatch is producing a lot of street-level experimentation and not nearly enough clinical data. Meanwhile, classical psychedelics — psilocybin in particular — are racing ahead in the trial pipeline, and the regulatory frameworks built for them may eventually drag cannabis research forward in their wake. For now, the most useful posture is curious skepticism. Take seriously that thoughtful psychiatrists see something worth studying. Take equally seriously that the same plant, used differently, contributes to real mental-health harm. Both can be true. Most plants worth knowing are complicated. If exploring this terrain through a structured container appeals to you, a range of ayahuasca, psilocybin, and other plant-medicine retreats can be browsed on our marketplace here. Whatever you decide, decide it slowly — the plants will still be there next month, and the right retreat is almost never the one you booked in a hurry.
Relapsed After Ibogaine? What to Actually Do Next
You did the thing. You flew somewhere, you sat in front of a facilitator, you swallowed the capsules, you spent thirty-plus hours inside the most disorienting experience of your life. You came home convinced — actually convinced, for the first time in years — that the loop was broken. And then, a week later, maybe two, you used again. If that's where you are right now, breathe. You haven't ruined anything. Ibogaine is one of the most powerful interventions we have for opioid and stimulant addiction, and it's also widely misunderstood — including by people who run retreats. A relapse after a flood dose isn't proof that the medicine failed you, and it isn't proof that you're hopeless. It usually means something much more specific, and once you understand what, you can do something about it. Here's something the glossier ibogaine clinics tend to soft-pedal: the post-treatment window is fragile. Studies and clinical reports going back decades — including work out of Mexico, Brazil, and New Zealand — suggest that while ibogaine can interrupt physical withdrawal and reset opioid tolerance dramatically, the durability of that reset depends almost entirely on what happens in the weeks and months after. The medicine creates an opening. It doesn't install a new life. People who relapse early are usually people who came home to the same apartment, the same phone contacts, the same job stress, the same untreated trauma, and the same lack of structured support. The plant gave them clarity. The environment gave them right back what it always gave them. There's also a strictly pharmacological piece worth knowing about, especially if opioids were your drug. Ibogaine wipes out tolerance fast. That means the dose you used to take — the one your body could handle three weeks ago — can kill you now. Post-ibogaine overdose deaths are almost always tolerance-related. If you've relapsed on opioids since treatment, please assume your tolerance is gone, get naloxone within arm's reach, and don't use alone. This is not optional advice. A lot of people walk out of an ibogaine ceremony believing the craving is permanently gone. For some, it really is — for a while. For others, the craving comes back in a couple of weeks, sometimes with a particular kind of confusion attached: wait, I'm supposed to be cured, why do I want this? That cognitive dissonance is often what makes the first relapse worse than it needs to be. You feel like you failed the medicine. You didn't. Ibogaine isn't a cure in the way antibiotics cure strep. It's closer to a surgical procedure on your psyche — it removes something, exposes something, makes a lot of new internal space — and the recovery from that surgery is a process. Most facilitators with real experience will tell you the work is at least 70% post-ceremony. The flood is the easy part. So a relapse means a few possible things, usually in combination: None of these mean the medicine didn't work. They mean the protocol around the medicine was incomplete. Practical first. Feelings later. Maybe. Probably not immediately. Here's the honest answer most retreat brochures won't give you. A second flood within a few months of the first is not usually recommended. Ibogaine puts real stress on the cardiovascular system, particularly the QT interval of the heart, and stacking flood doses too close together increases risk without much added benefit. Some clinics offer smaller follow-up or booster doses in the months after a flood — these are sometimes useful, but they're not a substitute for the actual recovery work. A more useful question than "should I do it again" is "what was missing the first time?" If you did a weekend at a clinic with no integration support, no follow-up calls, no therapist relationship, no community — yeah, you might benefit from another round, but only if you build a real container around it this time. A second ceremony into the same vacuum will probably give you the same result. Some people find that switching plant medicines helps. Ayahuasca, for instance, tends to do different work than ibogaine — more emotional, more relational, often more about grief and self-forgiveness than about the hard reset ibogaine offers. Others find that the slower, gentler work of psilocybin-assisted therapy fits better at this stage. There's no universal sequence. Pay attention to what your nervous system seems to be asking for. If you take one thing from this article, take this: integration is not a vibe. It's a structure. People who stay clean after ibogaine almost universally have some combination of the following pieces in place. You can build most of this in two or three weeks if you make it a priority. Most people don't, because in the afterglow it feels unnecessary, and by the time it feels necessary they're already in the relapse. Plant medicine is real. Ibogaine is real. The neuroplasticity window after a deep psychedelic experience is real, and there's good science behind why your brain is unusually open in the weeks following a flood. But none of that does the recovery for you. The people I've watched stay clean after ibogaine — five years out, ten years out — describe the medicine as a door. They walked through it. Then they spent years building a life on the other side that was worth not leaving. The medicine bought them a chance. They did the rest. If you relapsed, you still have the chance. The opening ibogaine created in your nervous system doesn't slam shut the day you use. It narrows. But there's still a window, especially if you act quickly, get honest, and rebuild the scaffolding that should have been there the first time. For readers thinking about whether a more supported approach — somewhere with serious medical screening, real integration, and aftercare that lasts beyond the goodbye hug — might be worth exploring, a range of vetted ibogaine and plant-medicine retreats can be browsed on our marketplace here. Choose carefully. The right container is most of the work.
What an Ayahuasca Ceremony Actually Feels Like: One Honest Account
The first time someone told me about ayahuasca, I thought they were describing a particularly intense stomach flu with a soundtrack. You drink something disgusting, you throw up for hours, and then you understand your childhood? Sure. Sign me up. Except — and this is the thing nobody quite prepares you for — that's almost exactly what happens. And almost nothing like what happens. Both at once. If you're researching whether to sit in your first ayahuasca ceremony, you've probably read a dozen sanitized retreat descriptions full of words like transformation and sacred. What follows is the version your friend would tell you over the second beer, after the polite version wore off. Most first-timers don't arrive at an ayahuasca retreat because they're curious about Amazonian botany. They arrive because something in their life has gotten loud enough that they're willing to fly to a jungle and drink a bitter tea that makes them vomit. Depression that won't lift. A grief that keeps circling back. A pattern in relationships they can see clearly and still can't stop repeating. Sometimes addiction. Sometimes a low, persistent sense that the life they're living isn't the one they meant to be living. For me, it was the quieter version of all that — a stuck feeling of being alone in a way that long predated being physically alone. The kind of thing that talk therapy could circle for years without quite landing on. When the word ayahuasca started appearing in three separate conversations in the same week, including one with someone who'd assisted at ceremonies, I took the hint. Call it synchronicity, call it the algorithm of paying attention. Either way, I booked a weekend. Different facilitators recommend different things, and the range is wide. Some ask only that you skip alcohol for a day or two. Others want a strict dieta for a full week: no sugar, no dairy, no wheat, no caffeine, no pork, no fermented foods, no sex, no recreational drugs. The pharmacological reason matters — ayahuasca contains MAO inhibitors, and certain foods and medications can interact dangerously with them. Specifically, anything containing tyramine (aged cheeses, cured meats, fermented soy) and most antidepressants, especially SSRIs and SNRIs, can become genuinely risky. This is the part where I'll say something nobody loves hearing: if you're on antidepressants, you must talk to a doctor and the retreat facilitators before you go. Don't quit your meds on a whim and don't show up without disclosing them. Reputable retreats screen for this. The ones that don't are the ones to walk away from. Beyond the physical preparation, I quit social media for the week, ate plainly, and spent the long drive to the retreat in silence. No podcast, no playlist. I set an intention — something about wanting to meet the part of myself I'd been avoiding — and then, on the advice of someone who'd done this before, I deliberately tried to let the intention go. The brew doesn't tend to deliver what you order. It delivers what's underneath the order. Thirteen of us, mostly women, on mattresses arranged in a circle around an altar of flowers and candles. White clothing. A pair of facilitators with guitars. A bucket beside each mattress — yours, personally, for the inevitable. The atmosphere was less Burning Man and more church potluck where everyone happens to know they're about to be turned inside out. The first cup is offered with a small bow. The liquid is the color of strong tea steeped in coffee grounds, and it tastes like both, if both had spoiled. People who say it's not that bad are lying or have damaged taste buds. A slice of citrus afterward helps for maybe four seconds. Then you walk back to your mattress and you wait. For roughly fifteen minutes, nothing happens except a slow rearrangement of your stomach's opinion about being a stomach. Then the facilitators start singing — icaros, the traditional songs that guide a ceremony — and somewhere around the second or third song, the room begins to tilt in a way that isn't really tilting. The visuals come first for some people. For me it was sound: a kind of busy static in my head, like every unfinished thought I'd had for a year showed up to a meeting at the same time. Ayahuasca is sometimes called la purga, and the name is accurate but incomplete. Yes, most people throw up. Some cry hard for hours. Some shake. Some have to run to the bathroom in the other direction. The purge isn't a side effect — facilitators and traditional drinkers consider it part of the medicine, the body's way of releasing something that's been stored where talking can't reach. What surprised me is how un-horrible it was in the moment. The energy that builds before a purge feels less like nausea and more like a wave with somewhere it needs to go. I didn't end up vomiting that first night — a small voice somewhere in the noise told me there was nothing for me to release that way, which I couldn't have argued with even if I'd wanted to. Other people in the circle purged for what felt like hours. By morning, several of them looked lighter in a way I can only describe as physical. A short, honest list of things that may happen during a ceremony: Two hours in, when the first wave is fading, the facilitators offered a second cup. This is standard at most ceremonies and the dose is usually smaller. The second drink tends to deepen what's already happening rather than start something new. For me, the second cup was where the noise quieted and something else moved in. I lay on my back and watched the room from upside down. I sat up and watched it right-side up. I noticed I'd been crying for what must have been a long time without registering it, and even that — even the wet cheeks — felt like something I was witnessing rather than doing. The phrase that kept arriving was simple and almost embarrassing in its plainness: without the stories you attach to things, things are just things. Not a revelation that would survive being printed on a coffee mug. But in the moment, it landed in my body in a way that no amount of reading had ever managed. I'll be honest about the part the brochures skip. Ayahuasca is not a one-night cure. People who go in expecting their depression, addiction, or trauma to be lifted out of them by morning often leave disappointed, or worse, convinced they did something wrong. The actual work is integration — the weeks and months after, when you have to take whatever you saw and translate it into how you live. Some of what shifted for me stuck. Some of it faded back into the noise of regular life within a month. The shifts that lasted were the ones I made decisions around: changing what I ate, who I spent time with, how I responded when the old stuck feelings came back. The shifts that faded were the ones I expected to maintain themselves. If you're considering a retreat, a few honest things to weigh: I can't answer that for you and I'd be suspicious of anyone who claimed to. What I can say is that the people I've watched genuinely benefit from ayahuasca tended to share a few things in common: they came to it after exhausting more conventional avenues, not before; they chose their retreat carefully and unhurriedly; they took integration as seriously as the ceremony itself; and they arrived with humility rather than a shopping list of outcomes. Ayahuasca is one of several master plants people are turning to as part of a broader rethink of how we heal — alongside psilocybin, ibogaine for addiction recovery, San Pedro, and others. It isn't a shortcut, and it isn't for everyone. But for some people, in the right setting, with the right preparation, it does something that nothing else has managed to do. If that possibility is what brought you here, and you'd like to take a closer look at what's actually available, a curated range of ayahuasca retreats and ceremonies can be browsed on our marketplace here. Whatever you decide, decide it slowly. The vine has been around for thousands of years. It will still be there next month.
Can Ibogaine Break Opioid Dependence? An Honest Look at Recovery
Somewhere around the second or third week of trying to taper off opioids on your own, a particular kind of desperation sets in. You start typing things into search bars at 2 a.m. that you'd be embarrassed to say out loud. Things like: can ibogaine actually kick this? If that's how you found your way here, welcome. You're not alone, and the question is a fair one. Ibogaine sits in a strange corner of the psychedelic and plant-medicine world. It's the one substance that addiction researchers keep circling back to, the one ex-users keep writing about years later, and the one almost no doctor in the United States can legally prescribe. So let's talk plainly about what it does, what it doesn't, what the risks actually are, and how someone weighing a retreat should think about the decision. Ibogaine is an alkaloid extracted from the root bark of the iboga shrub, which grows in West and Central Africa. The Bwiti tradition in Gabon has used it ceremonially for generations, in initiation rites that look nothing like the clinical detox protocols you'll find at modern retreats. Worth keeping that distinction in mind — Western ibogaine clinics borrowed the molecule, not the cosmology. Pharmacologically it's a beast. Ibogaine and its metabolite noribogaine hit a wide spread of receptors — opioid, serotonin, NMDA, sigma, nicotinic — and seem to do something genuinely unusual to the brain's reward circuitry. The short version, drawn from both clinical research and decades of underground reports: a single high dose appears to reset opioid tolerance and dramatically blunt acute withdrawal. People who walk into a clinic dope-sick often walk out, somewhere between 24 and 48 hours later, with the worst of the physical withdrawal already behind them. That's the part that makes it sound like a miracle. The fuller picture is messier. This is the question I see most often from people in the early research stage, so let's give it a real answer. For short-acting opioids — oxycodone, heroin, fentanyl — ibogaine has a relatively well-documented track record of interrupting acute withdrawal. The mechanism isn't perfectly understood, but the experience reported by participants is remarkably consistent: the bone-deep ache, the restless legs, the nausea, the crawling skin — much of it lifts during or shortly after the experience. Several open-label studies and observational reviews back this up, though we're still waiting on the large randomized trials that would settle the question for regulators. Suboxone (buprenorphine) is a different story, and anyone considering a retreat needs to hear this clearly. Buprenorphine has a long half-life and binds tightly to opioid receptors. Most reputable ibogaine providers will not accept a client who's still on suboxone — they require a switch to a short-acting opioid for several weeks beforehand, then a brief abstinence window before dosing. Trying to skip that switch tends to produce a much rougher experience, a less complete withdrawal interruption, and sometimes cardiac complications. If a clinic is willing to dose you straight off suboxone with no preparation protocol, that's a serious red flag. Methadone is even harder. Some providers won't take methadone clients at all. Others require months of careful tapering and substitution first. Ibogaine can stop your heart. That's not hyperbole — it's the central reason this is a clinical-grade intervention, not a weekend ceremony. Ibogaine prolongs the QT interval on an EKG, which in vulnerable people can trigger fatal arrhythmias. Documented deaths from ibogaine sessions almost always involve one or more of the following: A serious ibogaine retreat will require, at minimum: a recent EKG, comprehensive bloodwork, liver function tests, a full medication and substance history, and continuous cardiac monitoring during the experience itself. There should be a medical doctor on site — not on call, on site — with the equipment to manage an arrhythmia if one develops. If any of that is missing, walk away. The price difference between a properly medicalized program and a cheap one is the price of your life, and that math is not abstract. Forget anything you've heard about psychedelics being euphoric or blissful. Ibogaine isn't that. People who've been through it describe it as long, demanding, and frequently uncomfortable — closer to neurological surgery than a mystical journey, at least in the early hours. The first phase, the so-called visionary state, typically begins within an hour or two of dosing. Eyes-closed visuals come on, often described as watching a film of your own life — childhood scenes, faces of people you've hurt, the moment your using began, the people you've lost. It's autobiographical and often confrontational. People cry. People get quiet. Some report meeting something that feels like a presence, though the framing depends entirely on the person's background and beliefs. The second phase is introspective and analytical — more like lying in the dark thinking very clearly about your life for many hours, with the body heavy and motion uncomfortable. The third phase is exhaustion. Sleep often won't come for 24 to 36 hours after dosing, even though the body badly wants it. The whole arc, from dose to feeling somewhat normal again, runs three to five days. And then comes the part the brochures really don't emphasize: the afterglow window. Many people describe a stretch of weeks — sometimes months — where cravings are dramatically reduced and the old mental loops feel quieter. This is the window where the actual recovery work has to happen. Ibogaine doesn't build a new life for you. It opens a door. What you do in the months after determines whether you walk through it. If you're seriously considering this, a few practical filters that have served readers well: Readers often ask how ibogaine stacks up against ayahuasca or psilocybin for addiction recovery. Honest answer: they do different jobs. Ayahuasca tends to work over multiple ceremonies, addressing the emotional and trauma roots that drive substance use. It doesn't directly interrupt physical withdrawal the way ibogaine does. People with active opioid dependence usually need to stabilize before an ayahuasca retreat will be useful — many traditional centers won't accept active opioid users at all. Psilocybin shows promising results in early trials for alcohol use disorder and tobacco cessation, but it's not a withdrawal-interruption tool either. Its strength is in shifting the underlying patterns of thought and self-concept. Ibogaine is the one that addresses the physical hardware directly. For someone deep in opioid dependence, it's often the most realistic doorway — followed, ideally, by other modalities once the body is no longer the emergency. If you've read this far, you're doing the right thing. Researching slowly, asking hard questions, and refusing to romanticize a powerful intervention is exactly the posture that gets people through this in one piece. Ibogaine is not magic, but for the right person, with the right medical container and a serious commitment to the work that follows, it can be the thing that finally interrupts a pattern that's resisted everything else. If something here lands with you, the medically-screened ibogaine and plant-medicine retreats discussed throughout this piece can be browsed on our marketplace here. Take the time you need, ask the uncomfortable questions, and trust the people who answer them straight.
Craving More Stories?
Join our ShopAyahuascaRetreats newsletter for the latest updates on thrilling
destinations and inspirational tales, delivered straight to your inbox!
We value your privacy. Your email address will never be shared or published.
Is Ibogaine a Mindfulness Pill? What the Iboga Experience Really Teaches
Someone asked me last year, half-joking, whether iboga was basically a mindfulness pill. The kind of thing you swallow when sitting on a cushion for ten years feels like too long a wait. I laughed. Then I thought about it for a week. Because the question, underneath the flippancy, points at something real. People who've sat with iboga — or its pharmaceutical cousin ibogaine — often describe an experience that sounds suspiciously close to what long-term meditators report: an unflinching look at their own conditioning, the loosening of compulsive patterns, a strange and uncomfortable clarity about who they've been. So is it a shortcut? Is it cheating? Is it even the same thing? I want to talk through this honestly, because I think the answer matters — especially if you're someone weighing whether to fly to Mexico or Costa Rica or Portugal and hand yourself over to a facilitator with a root bark and a stethoscope. Mindfulness, in the way it's taught now, usually means non-judgmental awareness of the present moment. You notice what's happening — thoughts, sensations, emotions — without grabbing at it or pushing it away. Done consistently over years, it tends to produce people who are less reactive, more present, better at noticing the gap between stimulus and response. That's the public-facing version. The deeper claim of contemplative traditions is bigger: that sustained practice reveals something about the nature of the self. That the “you” running the show is more constructed and more porous than it feels. Buddhist teachers have been pointing at this for two and a half millennia. It's not a productivity hack. It's a slow-motion ontological audit. Here's where iboga gets interesting. Because whatever else it does, it forces an audit. It just does it in fourteen hours instead of fourteen years. Iboga is the root bark of Tabernanthe iboga, a shrub native to Central Africa, used ceremonially for centuries by the Bwiti tradition in Gabon. Ibogaine is the principal alkaloid, extracted and used in clinical and retreat settings — most famously as a treatment for opioid and stimulant addiction. The two are related but not identical experiences. The whole-root ceremony tends to feel more textured and more guided by the plant's own logic; ibogaine in a clinic setting can feel more pharmacological, more medical. Either way, the experience is long. We're talking 12 to 36 hours of altered consciousness, with the most intense phase lasting maybe eight to twelve. People often describe two distinct stages. The first is sometimes called the “visionary” phase — a flood of memories, images, and what feels like a structured review of one's life. Not random imagery. Specific scenes, specific people, specific moments where you made a choice that set a pattern in motion. The second phase is quieter and stranger. The visions fade and you're left lying in the dark, mostly awake, watching your own mind work without the usual filters. This is the part that participants frequently describe as “meditation-like,” though it's a meditation you didn't sign up for and can't end early. Yes and no. Let me explain. The yes: iboga absolutely does produce states of detached, observational awareness. People come out of ceremonies describing days or weeks of unusual clarity — they can see their habitual reactions before they fire, they notice cravings without acting on them, they catch themselves in the middle of an old story and just… don't finish telling it. That's recognizably what mindfulness practice is supposed to deliver. There's emerging research suggesting ibogaine affects neuroplasticity in ways that may temporarily increase this kind of metacognitive capacity. The no: a pill that gives you the view for a month is not the same as a practice that gives you the legs to keep walking. Plenty of people have profound iboga experiences and slide right back into the patterns they thought they'd seen through. The experience hands you a map. It doesn't hand you the discipline to actually use it. This, by the way, is where iboga differs sharply from ayahuasca or psilocybin in the cultural conversation. Iboga isn't really sold as a journey. It's sold as a confrontation — particularly for people struggling with addiction. The marketing language around it is less “heart-opening” and more “interrupting a death spiral.” Which is closer to the truth. The reason ibogaine has built a reputation outside the broader psychedelic conversation is its effect on opioid dependence. People with heroin or fentanyl addictions report walking out of an ibogaine treatment with their withdrawal symptoms gone and their cravings dramatically reduced. This isn't a small thing. It's the closest thing the addiction field has to a chemical reset button — and that's why underground and offshore clinics have been running treatments for decades despite ibogaine being a Schedule I substance in the United States. But — and this is critical — ibogaine is not safe in the casual way some other plant medicines can be approached. It's cardiotoxic. It can cause fatal arrhythmias in people with undiagnosed heart conditions or certain medication interactions. Reputable clinics require EKGs, bloodwork, and medical supervision throughout. If you're researching ibogaine and a provider doesn't mention any of this, walk away. I mean it. A few things worth knowing if you're considering it: In the Amazonian traditions, ayahuasca isn't the only “master plant” — there's a whole pharmacopoeia of teachers, each said to offer a particular kind of instruction. Iboga sits in a parallel category from a different continent. The Bwiti tradition treats it not as a substance but as a teacher, an ancestor, something you enter into relationship with. That framing matters because it pushes back against the “mindfulness pill” idea. You don't take a master plant. You consult one. And the consultation, if you're paying attention, includes homework. The visions show you what's broken. The integration phase is when you decide whether to actually fix it. People who treat iboga as a one-shot fix tend to be disappointed. People who treat it as the beginning of a longer practice — therapy, meditation, lifestyle change, community — tend to be the ones whose lives actually shift. If you're researching iboga or ibogaine, start with brutal honesty about why. Are you looking for addiction recovery? A spiritual experience? Relief from depression that hasn't responded to anything else? Each of those points you toward different providers, different settings, different price points. A medical ibogaine clinic in Mexico is a very different proposition from a Bwiti-influenced ceremony in Costa Rica or Portugal. Both can be legitimate. Neither is interchangeable. Be skeptical of any provider promising transformation. Be more skeptical of one promising it without medical screening. And give yourself a serious think about what you'll do for the six months after — because that's the part that determines whether the experience becomes a turning point or a story you tell at parties. For readers wanting to take this further, a range of vetted ibogaine and plant-medicine retreats can be browsed on our marketplace here. Whether iboga is a mindfulness pill or not, it's a serious tool — and the people who get the most out of it tend to be the ones who treat it that way from the first phone call.
Psychedelic Water Review: Does Kava Really Replace Your Evening Drink?
A friend of mine cracked open one of these cans at a backyard dinner last summer and someone immediately asked if she was tripping. She wasn’t. She was drinking what looked like a hard seltzer, was called Psychedelic Water, and contained roughly zero psychedelics. The name does a lot of heavy lifting — some of it useful, some of it misleading. I spent about a month using it the way the marketing suggests: as the thing in my hand at gatherings where everyone else was reaching for a margarita. I’m not strictly sober, I just have terrible hangovers and a low tolerance for the slow social erosion that comes with regular drinking. So this counted as a real experiment, not a stunt. Here’s what I learned about the drink, the ingredients, and the broader trend it rides on — including how it overlaps (and doesn’t) with the actual world of psychedelics and plant medicine. The headline ingredient is kava — a root from the South Pacific that islanders have used in social and ceremonial settings for centuries. Traditional kava is prepared by pounding or grinding the root and mixing it with water until you have something resembling muddy dishwater that tastes, frankly, the way it looks. The canned version is a much gentler product: kava extract, damiana leaf (a mild relaxant with a long history in Central America), green-tea extract for a small caffeine lift, and flavoring. Four flavors are in rotation — hibiscus lime, blackberry yuzu, oolong orange blossom, and prickly pear. Prickly pear is the one to start with. What kava does in the body is sedative-adjacent. It binds to GABA receptors, which is the same general pathway alcohol and benzodiazepines use, although kava is far gentler. You feel a softening of the edges. A loosening in the shoulders. Conversation feels easier without the sloppy disinhibition booze gives you. The National Institutes of Health notes that kava supplements have shown a small effect on reducing anxiety in clinical studies — modest, but real. One thing worth flagging up front: kava has been linked in rare cases to liver injury, especially when used heavily or combined with alcohol or certain medications. If you’re on prescription meds, drink regularly, or have any liver concerns, talk to a doctor before making this a habit. The occasional can at a dinner party is a different beast than daily use. Let’s clear up the obvious confusion first. Psychedelic Water is not psychedelic. There is no LSD, no psilocybin, no DMT, no mescaline. You will not see geometric patterns. You will not have an ego-dissolution experience in your kitchen. The name is a marketing choice — provocative, memorable, and arguably useful in the way it nudges the word “psychedelic” into ordinary supermarket vocabulary, but the can itself is closer to a fancy herbal tea than to anything you’d find at an ayahuasca retreat. What it actually feels like, for me, was a soft 20-minute onset of mild calm. A faint tingle on the tongue (kava does that — it’s a quirk of the active compounds called kavalactones). A small lift in mood that didn’t spike or crash. After two cans across an evening I felt loose-jawed and content. After three I felt slightly queasy and had a dull stomach ache, so I’d say two is the practical ceiling. The most useful comparison I can give: it sits somewhere between chamomile tea and a single glass of wine on the relaxation spectrum, minus the next-day fog. I slept well. I woke up sharp. I did not text anyone something I regretted. By the modest standards of a Tuesday night, that’s a win. Nonalcoholic-beverage sales jumped roughly a third year-over-year a couple of years back, and the curve has kept climbing since. The category that used to mean O’Doul’s and grape juice now includes adaptogenic sodas, hemp-derived seltzers, functional mushroom blends, and a whole subgenre of kava drinks. Psychedelic Water is one of the louder voices in that crowd, partly because of TikTok and partly because of the name. The motivations behind sober-curious living are more varied than the wellness narrative suggests. Yes, some people are quitting for health. But just as many cite productivity, mental clarity, sleep quality, and the simple math of not wanting to feel rotten on Saturday morning. Younger drinkers are also doing it for cost — alcohol is expensive — and for the fact that they’ve grown up watching the long-term damage it does to the people around them. That last one matters more than people admit. Alcohol is a pretty effective short-term anesthetic. Take it away and a lot of stuff surfaces — restlessness, sadness, the patterns you’ve been numbing for years. Some people find that uncomfortable and circle back. Others find it’s the doorway they didn’t know they were looking for. Here’s where it gets interesting for anyone who lands on a drink like this and starts wondering what else is out there. Kava is, in the broadest sense, a plant medicine. It’s a botanical with psychoactive properties used ceremonially by an indigenous culture for generations. That puts it in the same loose family as ayahuasca, San Pedro, peyote, and the other master plants — but the family is very, very loose. Kava sedates. Ayahuasca rearranges your sense of reality for six hours and shows you the contents of your own mind. They are not the same tool. I’ve sat in a number of ayahuasca ceremonies and interviewed facilitators across Peru, Costa Rica, and the Netherlands. The thing readers most often miss is that the “psychedelic” part of psychedelics isn’t about visuals or recreation — it’s about a temporary suspension of the usual mental machinery that lets you see your patterns, your trauma, your addiction, your grief, with unusual clarity. That’s why these medicines have become a serious conversation in addiction recovery, depression treatment, and PTSD therapy. Compounds like psilocybin and ibogaine are now in late-stage clinical trials for exactly those uses. A canned kava drink will not do any of that. What it might do, honestly and usefully, is start a conversation. If you’re someone who picks up a can called Psychedelic Water at a dinner party and finds yourself curious — really curious — about what the word actually means, that curiosity is worth following. Read about the Indigenous traditions. Read the Johns Hopkins research. Talk to people who’ve done the work. Don’t confuse a beverage with a ceremony. If you’re looking for a smarter thing to hold at a party, or a wind-down drink that won’t cost you Sunday morning, this category is worth exploring and Psychedelic Water is a reasonable entry point. Go in with realistic expectations. You’re buying a mild herbal relaxant in a stylish can, not a portal to anywhere. Pay attention to how your body responds, don’t mix it with alcohol or sedatives, and skip it entirely if you’re pregnant, on liver-sensitive meds, or drinking heavily already. And if the experiment leaves you genuinely interested in what plant medicines can do at the deeper end — addiction work, trauma work, the kind of inner inventory that actually changes a life — there’s a much larger world waiting. A growing range of ayahuasca, psilocybin, and other plant-medicine retreats can be browsed on our marketplace here, with facilitators and traditions worth taking seriously. Start with the can if you want. Just know that the can is the beginning of the question, not the answer.
Shamanism, Plant Medicine, and the Ancient Science of Altered States
Long before anyone called it neuroscience or wrote a peer-reviewed paper about psilocybin, people in nearly every corner of the planet were already doing the work. Sitting in caves. Drumming for hours. Drinking bitter brews made from vines and bark. Coming back changed. This is the strange, persistent fact at the heart of shamanism — that humans, separated by oceans and millennia, kept arriving at the same techniques for entering altered states. Rhythm. Fasting. Sacred plants. Movement. And then they kept using those states for the same purposes: healing the sick, settling communal disputes, finding game, mapping the unseen, and locating the human inside a larger living web. For anyone considering an ayahuasca retreat or any kind of psychedelic ceremony today, this older lineage matters. It's the soil the modern conversation grew out of. Anthropologists have been arguing for a century about whether ‘shamanism' is one thing or many. The honest answer is: both. Siberian healers, Amazonian curanderos, southern African sangomas, and Mongolian buryat shamans don't share a religion. They share a toolkit. Trance. Spirit communication. Healing through ritual. A sense that the natural world is alive and conversational. What's striking is how often the toolkit overlaps in oddly specific ways. Hand drums and rattles. Animal mimicry in dance. Plant preparations passed down through apprenticeships that can last a decade. The shaman as a kind of community generalist — part doctor, part priest, part field botanist, part therapist, part diplomat with the more-than-human. Researchers like Michael Winkelman have argued that shamanism is essentially a neurotheology — a set of practices our species figured out, by trial and error, for working with the human nervous system. Different cultures, similar machinery, similar results. The drum is the most underrated technology in human history. Rock art from over ten thousand years ago shows figures holding frame drums and rattling staffs. Modern EEG studies have found that steady percussion in roughly the 4–7 Hz range nudges the brain toward theta-wave activity — the same territory where vivid imagery, dream-logic, and creative insight tend to live. That's not mystical. That's measurable. Rhythmic auditory driving, as researchers call it, entrains neural oscillations. Combine it with controlled hyperventilation, fasting, sleep restriction, and hours of repetitive movement, and you have a reliable recipe for getting the ordinary mind to step aside. Add a sacred plant on top of that, and you're working with something even more potent. Some of the oldest decorated caves in Europe — Lascaux, La Garma — turn out to have peak acoustic resonance right around 110–120 Hz, frequencies linked to altered consciousness in laboratory studies. The painters seem to have chosen these chambers deliberately. Firelight on painted animals, voices and drums bouncing off curved stone, hours of preparation. A multimedia immersion designed thousands of years before anyone had the word. Ayahuasca didn't appear in a clinical trial in 2015. It's been brewed in the western Amazon for at least four thousand years, possibly longer. Peyote use in what's now northern Mexico shows up in archaeological sites dating back roughly six thousand years. San Pedro cactus residues in Peru go back further still. The idea that psychedelics are a counterculture invention is, frankly, a little embarrassing once you look at the timeline. Traditional healers refer to these botanicals as master plants — teachers, not products. The framing matters. A master plant isn't a substance you consume to feel something; it's a being you enter into relationship with, usually after extensive preparation, dietary restriction, and apprenticeship. Curanderos in the Amazon will tell you the plant chooses you as much as you choose it. You can take or leave that metaphysically. Pragmatically, the framing tends to produce more careful, more integrated experiences. The ayahuasca brew itself is a piece of pharmacological brilliance. The vine Banisteriopsis caapi contains MAO-inhibitors. The leaves of Psychotria viridis contain DMT, which would otherwise be broken down in the gut before reaching the brain. Combine them, and the DMT becomes orally active. How an illiterate forest culture worked this out, from roughly 40,000 plant species in the Amazon basin, is one of those questions ethnobotanists shrug at and call ‘plant intelligence' or ‘the dreams told us,' depending on who you ask. The renewed scientific interest in psychedelics over the past two decades has, in many ways, confirmed what shamans have been saying for generations. Studies at Johns Hopkins, NYU, and Imperial College London have found that psilocybin and ayahuasca, used in supportive ceremonial-style settings, can produce lasting reductions in depression, treatment-resistant anxiety, and substance use disorders. Ibogaine has shown remarkable results for opioid addiction in clinical contexts — sometimes interrupting decades-long patterns in a single session. What's interesting is that the size of the therapeutic effect seems to correlate with the depth of what participants describe as the mystical experience itself. The science is essentially measuring the same thing the curanderos were pointing at: a profound shift in self-perception and meaning, followed — if integrated well — by changes in behavior. That last clause is the one most often glossed over in the breathless coverage. Plant medicine for addiction recovery, plant medicine for depression, plant medicine for trauma — these are real possibilities, but they live or die on what happens after the ceremony. Integration is the unglamorous part. The journaling, the therapy sessions, the changed routines, the awkward conversations. Without it, even the most cinematic vision tends to fade like a dream you can't quite hold onto by lunchtime. One of the things that gets lost when shamanism is reduced to ‘ancient psychedelic therapy' is the worldview it sits inside. Animism — the perception that rivers, mountains, plants, and animals possess their own inner life — isn't a quaint primitive belief. It's a functioning ecological operating system. When the forest is full of persons rather than resources, you treat it differently. You take only what's needed. You ask permission. You give back. Traditional ecological knowledge, accumulated over generations of this kind of attentive reciprocity, has repeatedly turned out to be more accurate than outside experts assumed. Fire management in Australia. Forest gardening in the Amazon. Fisheries practices in the Pacific Northwest. The shamanic worldview produced not just visionary experiences but functional environmental science — encoded in story, song, and ritual rather than journals and graphs. This is part of why people walking out of an honest ayahuasca ceremony often describe feeling, for the first time, that the natural world isn't a backdrop. It's a participant. That shift, more than any single insight, is what tends to outlast the experience itself. If you're researching plant medicine because something in your life has hit a wall — addiction, depression, a grief you can't move through, a sense of being stuck inside your own head — knowing this longer history is useful for a few practical reasons. First, it should calibrate expectations. Shamanic cultures don't treat ceremony as a one-shot fix. They treat it as part of a longer arc that includes preparation, multiple sessions, dietary restriction, and a community to come home to. Retreats that promise transformation in a single weekend with no follow-up are missing most of the architecture that made these practices work for thousands of years. Second, it should sharpen your discernment when choosing a retreat. Reputable centers will talk openly about lineage — who their facilitators trained with, how long, in what tradition. They'll screen you medically and psychologically. They'll provide structured integration support afterward, not just a goodbye hug at the airport. They'll be honest about risks: difficult experiences, medication interactions, the real possibility that you come back rattled before you come back better. Third, it should remind you that the substance is a small part of the medicine. The container — the people, the place, the songs, the intention, the integration — does most of the actual work. A skilled facilitator working with mushrooms in a quiet farmhouse can produce more healing than a chaotic retreat charging four times the price. For readers who want to take this further, a curated range of ayahuasca and plant-medicine retreats can be browsed on our marketplace here. Whatever path you choose, take it slowly. The plants have been here for thousands of years. They'll still be here when you're ready.
Ibogaine Aftermath: Double Vision, Insomnia, and Body Temperature Swings Explained
Three days after a flood dose, you finally try to read something on your phone and the letters won't sit still. Sleep comes in 40-minute scraps. Your hands feel hot, your feet feel like ice, and your heart seems to be reporting from another time zone. Sound familiar? If you've recently sat with ibogaine — or you're researching what the recovery actually looks like before booking a retreat — this is the conversation nobody puts on the glossy brochure. Ibogaine is one of the most powerful tools in the plant medicine and psychedelic world for breaking addiction, particularly opioid dependence. It's also one of the most physiologically demanding. The aftermath can stretch out for weeks. Knowing what's normal, what's annoying, and what's a red flag matters. Most psychedelics clear your system in hours. Ibogaine doesn't play by those rules. The active alkaloid metabolizes into noribogaine, which binds to fat tissue and slowly releases back into circulation for days — sometimes weeks. That's part of what makes ibogaine so unusual for addiction work: the afterglow has a pharmacological tail. It's also why people report odd, lingering effects long after they assumed they'd be back to baseline. Noribogaine continues to nudge serotonin, dopamine, and opioid receptors. Your nervous system, meanwhile, has just been through something closer to a controlled crisis than a typical ceremony. The autonomic system — the one that runs your heartbeat, body temperature, digestion, and sleep — takes time to recalibrate. So when people show up in forums asking about double vision, insomnia, and thermoregulation chaos, they're not imagining things. These are documented post-ibogaine experiences. Across facilitator notes, harm-reduction guides, and the people I've talked with after their retreats, three after-effects come up over and over in the first one-to-four weeks: None of these are particularly fun. Most of them resolve on their own. But they're worth understanding so you can tell ordinary recovery from something that needs attention. During the ibogaine experience itself, eyes-closed visuals are part of the territory — the rapid film-reel of memories that the medicine is famous for. Afterwards, some people notice their eyes feel uncoordinated for days. Reading is hard. Phone screens blur. Driving feels unsafe. The mechanism is ataxia — a temporary disruption in the cerebellum's coordination of fine motor movement, including the muscles that aim your eyeballs. Ibogaine is famously ataxic during the acute phase (you'll have been walked to the bathroom by a facilitator for a reason), and residual cerebellar effects can hang around. Most people see this clear up within a week or two. If it's still happening at the four-to-six-week mark, that's the point to see a neurologist rather than another forum. This one surprises people. You'd think a medicine that knocks you flat for 24 hours would leave you ready to sleep for a month. Instead, the opposite often happens. Many people report two, three, even five days of almost no sleep after a flood dose, followed by weeks of choppy, fragmented rest. Part of this is noribogaine's stimulant-like profile slowly tapering off. Part of it is that opioid withdrawal — if that's why you came to ibogaine in the first place — has its own insomnia signature that doesn't fully resolve when the acute withdrawal does. And part of it is simply that your nervous system has been turned inside out and is still finding its footing. Practical things that help: keep caffeine to a minimum, get morning sunlight on your eyes, eat real meals at regular times, avoid heavy screens before bed, and accept that sleep will be weird for a while. Magnesium glycinate at night helps some people. Melatonin is hit-or-miss after ibogaine — some find it useful, others say it makes the dreams more intense than they want. Thermoregulation is run by your hypothalamus, which sits at the intersection of the endocrine and autonomic nervous systems. Both of those systems got rattled. So it's not strange that for a few weeks, your internal thermostat seems broken. People describe sweating through sheets, then shivering in a warm room twenty minutes later. Hands and feet that won't warm up. A face that flushes for no reason. Layered clothing is your friend. So is staying well hydrated with electrolytes — sodium, potassium, magnesium — because ibogaine is hard on minerals and the residual effects can show up as temperature swings. Most after-effects fade. Some don't, and a few are genuinely dangerous. The two that demand immediate medical attention are anything cardiac and anything that looks like a prolonged QT-interval issue. Ibogaine prolongs the QT interval, which means it can predispose the heart to a specific kind of arrhythmia called torsades de pointes. This is why reputable retreats screen for cardiac risk with an EKG, magnesium and potassium bloodwork, and a careful medication review before they'll give you a dose. The risk window for QT prolongation extends well past the ceremony itself — some studies suggest two weeks or more. Get medical care immediately if, in the weeks after ibogaine, you experience: The vast majority of people who do ibogaine in a properly screened, properly supervised setting come through without any of these. The minority who run into trouble usually skipped the screening — either because they treated at home with no medical backup, or because the operation they went to wasn't actually running the tests they claimed to. This is where the booking decision really lives, in my view. Anyone can hand you a capsule. What separates a credible ibogaine provider from a sketchy one is what happens before and what happens after. Things to ask before you put a deposit down: A serious operation will have answers ready. A sketchy one will get vague, defensive, or pivot to talking about how powerful the medicine is. The medicine is powerful. That's the point. It's also why the wrapper around the medicine — the screening, the supervision, the integration — matters more than the medicine itself. Here's the thing about ibogaine specifically, as compared with ayahuasca or psilocybin: the post-acute window stretches longer because of that fat-stored noribogaine slowly trickling back into your bloodstream. Many people describe two to six weeks of feeling unusually open, emotionally permeable, sometimes raw. The cravings for the substance you came to address may be remarkably quiet. Old emotional material may keep surfacing. This is the integration window. It's a gift if you use it. Therapy appointments scheduled in advance, a support group, a sober community, daily walks, journaling — the unglamorous infrastructure of recovery — work better in this window than at any other time. People who waste it tend to find the cravings creeping back. People who use it tend to describe ibogaine as the most useful single event in their recovery, even years later. If you're still researching whether this path is right for you, take your time. Read survivor accounts, read the harm-reduction literature, talk to people who've done it. For readers who want to take this further, a range of vetted ibogaine and plant-medicine retreats can be browsed on our marketplace here. The strange weeks after a flood dose aren't a sign that something went wrong. Usually they're a sign that something significant happened, and your body is still catching up. Treat that body kindly. Sleep when you can. Eat real food. Keep someone you trust in the loop. And if anything feels truly off — especially anything cardiac — don't tough it out. Get checked.
Psychedelics and Depression: What the Research Actually Shows About Plant Medicine for Healing
Depression is the most common reason people quietly start Googling ayahuasca at 2 a.m. I've sat across from dozens of them in pre-retreat interviews — engineers, mothers, recovering addicts, retired teachers — and the story is almost always the same. They've tried the medications. They've tried therapy. Something still isn't moving. So they start reading about psychedelics, and the research they find is genuinely encouraging. Here's what's actually known about psychedelics and depression in 2026, what's still uncertain, and what to think about if you're weighing a retreat as part of your own path forward. The World Health Organization estimates more than 280 million people live with depression worldwide. It's the leading cause of disability on the planet. And despite five decades of SSRIs, talk therapy, and an ever-expanding menu of treatments, the global numbers keep climbing — not falling. For roughly a third of people diagnosed with major depression, the standard tools don't work well enough. That's treatment-resistant depression: you've tried two or more medications at adequate doses, and you're still struggling. It's a brutal place to be, and it's the population most psychedelic studies have focused on. Major depression — the form most relevant to plant-medicine work — usually shows up as some combination of persistent low mood, exhaustion, anhedonia (the loss of pleasure in things that used to matter), isolation, and intrusive thoughts that don't quit. If any of that sounds familiar, you're not alone in turning over every stone. The first wave of psychedelic research began in the 1950s, mostly around LSD. It produced promising results, then was cut short by the political crackdown of the late 1960s. The work picked back up in the 1990s, and the past decade in particular has produced a body of evidence serious enough that institutions like Johns Hopkins, NYU, and Imperial College London have built dedicated psychedelic research centers. Across that work, a consistent pattern has emerged. When given in a supportive setting — careful screening, trained facilitators, integration support afterward — psychedelics appear to produce rapid and often long-lasting reductions in depressive symptoms. Not in everyone. Not as a magic bullet. But in proportions that traditional psychiatry hasn't seen in decades. A few of the substances that keep coming up: Each works differently. Each carries different risks. None should be approached casually. If you've read a news article about psychedelics in the last few years, it was probably about psilocybin. That's because it has the cleanest research record so far. A landmark 2016 trial at Johns Hopkins found that a single high-dose psilocybin session, paired with therapy, produced substantial and sustained drops in depression and anxiety among patients with life-threatening cancer. Follow-ups years later showed many of those benefits had stuck. Then came the Imperial College work led by Robin Carhart-Harris. Two doses of psilocybin, in patients whose depression hadn't responded to anything else, brought relief that lasted up to six months. His team's brain-imaging research suggested psilocybin temporarily quiets the default mode network — the part of the brain that runs the same loops of self-referential, often self-critical thought that characterize depression. When that network goes quiet, parts of the brain that normally don't talk to each other start communicating. People describe it as something loosening. One detail worth knowing: the patients who reported what researchers call a “mystical experience” during their session — a sense of unity, awe, or contact with something larger than themselves — were the ones most likely to see depression lift. The chemistry alone doesn't seem to be enough. The experience matters. Ayahuasca has been used ceremonially by Indigenous Amazonian communities for centuries. Western science showed up late to the conversation — most rigorous studies are from the 1990s onward — but the findings have been striking. A 2018 Brazilian randomized placebo-controlled trial gave ayahuasca to people with treatment-resistant depression. A single session produced rapid antidepressant effects that were still measurable a week later. As with psilocybin, brain imaging pointed to changes in the default mode network. Participants weren't just feeling better; the actual wiring of their rumination loops seemed to soften. What I've watched in person at retreats matches the data, with caveats. People who come in carrying years of depression often describe the ceremony as the first time in a long while they've felt something other than the weight. Not euphoria — more like a deep recalibration. Some cry for hours. Some sit in silence and watch their whole life play back. Some throw up a lot (the purge is a real and unglamorous part of the experience). Most report, in the weeks after, that the constant background noise of depression has gotten quieter. But ayahuasca is not gentle. It's a full-body, multi-hour journey. People with certain conditions — bipolar disorder, schizophrenia, a family history of psychosis, certain heart conditions, and anyone on SSRIs or MAOIs without proper medical tapering — should not drink it. A reputable retreat will screen carefully and turn people away. A bad one won't. Microdosing — taking sub-perceptual doses of LSD or psilocybin every few days — has become its own cottage industry. The anecdotal reports are everywhere: better mood, more focus, lifted depression, more emotional availability. The peer-reviewed research is more mixed. Several recent studies have suggested microdosing may produce real benefits, while others have found the effects are largely placebo. My honest read: microdosing might help some people some of the time, but it's not the same intervention as a full psychedelic-assisted session. The breakthroughs people describe from a single guided ayahuasca or psilocybin experience aren't typically what microdosers report. If your depression is severe, microdosing is unlikely to be the answer. If you're managing a mild rut and want to experiment carefully and legally, that's a different conversation. If you're considering plant medicine specifically because depression is grinding you down, here are the things I'd want you to know before booking anything. Psychedelics are not for everyone. People with bipolar disorder or a personal or family history of psychotic illness are excluded from research trials for good reason — the medicine can destabilize those conditions, sometimes severely. Pregnant women, people with significant cardiovascular disease, and anyone in acute crisis should not be drinking ayahuasca at a retreat in the jungle. Legality also matters. Ayahuasca exists in a gray zone in most countries; psilocybin therapy is becoming legal in specific jurisdictions (Oregon and Colorado in the U.S., for example), but recreational possession remains illegal almost everywhere. Many of the most-respected retreats operate in countries where the medicine is legal or culturally protected — Peru, Costa Rica, Brazil, the Netherlands, Mexico, Jamaica. And the research itself, while genuinely promising, is still young. We have strong signals, not final answers. A serious facilitator will tell you that. A salesperson won't. If you're depressed and reading this, the fact that the science is finally catching up to what Indigenous communities have known for centuries is, on balance, good news. Psychedelics aren't a shortcut around the hard work of recovery — they're a tool that, used with care, can crack open doors that have been welded shut for years. The decision to attend a retreat is personal, medical, and worth making slowly. Talk to your doctor. Talk to people who've done it. Read the trial results yourself. Trust your own pace. If something here speaks to you, the available psychedelic and plant-medicine retreats discussed throughout this piece can be browsed on our marketplace here — quietly, on your own time, with no pressure to do anything except keep learning.
Dreaming of a Psychedelic Retreat?
We have the best deals and offers from thousands of organizers all over the world! Get them into your mailbox every week!
We value your privacy. Your email address will never be shared or published.
